New inhibitor shows promise against metastatic prostate cancer

(Stony Brook University) When prostate cancer spreads it is often a deadly disease, but now a Stony Brook University-led research team believes a new approach that inhibits a specific fatty acid binding protein (FABP) may be the key to halting disease progression.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news